127 related articles for article (PubMed ID: 37753540)
1. Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Pelizzaro F; Trevisani F; Simeon V; Vitale A; Cillo U; Piscaglia F; Missale G; Sangiovanni A; Foschi FG; Cabibbo G; Caturelli E; Di Marco M; Azzaroli F; Brunetto MR; Raimondo G; Vidili G; Guarino M; Gasbarrini A; Campani C; Svegliati-Baroni G; Giannini EG; Mega A; Masotto A; Rapaccini GL; Magalotti D; Sacco R; Nardone G; Farinati F;
Liver Int; 2023 Dec; 43(12):2762-2775. PubMed ID: 37753540
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
4. Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.
Menahem B; Duvoux C; Ganne N; Mallat A; Seror O; Calderaro J; Launoy G; Alves A; Cherqui D; Luciani A; Laurent A
World J Surg; 2019 Jan; 43(1):221-229. PubMed ID: 30128773
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for recurrence beyond Milan criteria after radiofrequency ablation in transplantable small hepatocellular carcinoma.
Chu W; Li P; Wu X; Zhang P; Zhou H; Niu B
Rev Esp Enferm Dig; 2022 Oct; 114(10):580-585. PubMed ID: 35042367
[TBL] [Abstract][Full Text] [Related]
6. Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice.
Zhang XF; Xue F; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
J Gastrointest Surg; 2022 May; 26(5):1021-1029. PubMed ID: 34797558
[TBL] [Abstract][Full Text] [Related]
7. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation.
Zhang NN; Zheng J; Wu Y; Lv JY; Zhang SW; Zhang YM; Jiang WT; Song TQ; Kim V; Tohme S; Liu T; Zhang W; Gu J; Wang ZY; Suo YH; Wang S; Li W; Zhang L; Xie Y; Zhou YH; Liu JY; Qiu YB; Shen ZY; Hao JH; Geller D; Lu W
Cancer Med; 2023 Feb; 12(3):2312-2324. PubMed ID: 36016484
[TBL] [Abstract][Full Text] [Related]
9. Non-transplantable recurrence after percutaneous thermal ablation of ≤3-cm HCC: Predictors and implications for treatment allocation.
Gozzo C; Hermida M; Herrero A; Panaro F; Cassinotto C; Mohamad AM; Assenat E; Guillot C; Allimant C; Schembri V; Basile A; Dharancy S; Ursic-Bedoya J; Guiu B
Hepatol Commun; 2022 Oct; 6(10):2975-2987. PubMed ID: 35932178
[TBL] [Abstract][Full Text] [Related]
10. Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy.
Seo CG; Yim SY; Um SH; Lee YR; Lee YJ; Kim TH; Goh HG; Lee YS; Suh SJ; Han NY; Choi HS; Kim ES; Keum B; Seo YS; Yim HJ; Kim JH; Kim DS; Jeen YT; Chun HJ; Lee HS; Kim CD
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):532-542. PubMed ID: 31870653
[TBL] [Abstract][Full Text] [Related]
11. Histological differentiation predicts post-liver transplantation survival time.
Li WX; Li Z; Gao PJ; Gao J; Zhu JY
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
[TBL] [Abstract][Full Text] [Related]
12. Preoperative predictors of non-transplantable recurrence after resection for early-stage hepatocellular carcinoma: application in an East Asian cohort.
Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC
Updates Surg; 2022 Jun; 74(3):891-897. PubMed ID: 35023038
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
Lee KK; Kim DG; Moon IS; Lee MD; Park JH
J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma.
Meischl T; Rasoul-Rockenschaub S; Győri G; Scheiner B; Trauner M; Soliman T; Berlakovich G; Pinter M
United European Gastroenterol J; 2021 Mar; 9(2):209-219. PubMed ID: 32741316
[TBL] [Abstract][Full Text] [Related]
15. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
16. Liver Resection for Early Hepatocellular Carcinoma: Preoperative Predictors of Non Transplantable Recurrence and Implications for Treatment Allocation.
Gelli M; Sebagh M; Porcher R; Romanelli E; Vibert E; Sa Cunha A; Castaing D; Rosmorduc O; Samuel D; Adam R; Cherqui D
Ann Surg; 2020 Nov; 272(5):820-826. PubMed ID: 32833755
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
[TBL] [Abstract][Full Text] [Related]
19. Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma.
Kim JM; Joh JW; Yi NJ; Choi GS; Kim K; Lee KW; Suh KS
J Gastrointest Surg; 2020 Oct; 24(10):2219-2227. PubMed ID: 31482410
[TBL] [Abstract][Full Text] [Related]
20. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J
Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
